The magnitude of dengue virus NS1 protein secretion is strain dependent and does not correlate with severe pathologies in the mouse infection model

Journal of Virology

Volumn 86, Issue 10, 2012, Pages 5508-5514

  Watanabe, Satoru ^a   Tan, Kah Hin ^a   Rathore, Abhay P S ^a   Rozen Gagnon, Kathryn ^a   Shuai, Wang ^b   Ruedl, Christiane ^b   Vasudevan, Subhash G ^a  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; NONSTRUCTURAL PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIBODY SCREENING; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 2; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN PURIFICATION; PROTEIN SECRETION; STRAIN DIFFERENCE; VIREMIA; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS VIRULENCE;

AEDES; ANIMALS; CELL LINE; DENGUE; DENGUE VIRUS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, 129 STRAIN; SPECIES SPECIFICITY; VIRAL NONSTRUCTURAL PROTEINS; VIRULENCE;

DENGUE VIRUS;

EID: 84861302591     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.07081-11     Document Type: Article

References (34)

1. Alcon S, et al. 2002. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J. Clin. Microbiol. 40:376 -381.
2. Avirutnan P, et al. 2010. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J. Exp. Med. 207:793- 806.
3. Avirutnan P, et al. 2011. Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. J. Immunol. 187:424-433.
4. Avirutnan P, et al. 2006. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J. Infect. Dis. 193:1078 -1088.
5. Balsitis SJ, et al. 2010. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog. 6:e1000790.
6. Christenbury JG, et al. 2010. A method for full genome sequencing of all four serotypes of the dengue virus. J. Virol. Methods 169:202-206.
7. Chuansumrit A, et al. 2008. The use of dengue nonstructural protein 1 antigen for the early diagnosis during the febrile stage in patients with dengue infection. Pediatr. Infect. Dis. J. 27:43- 48.
8. Duong V, et al. 2011. Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity. PLoS Negl. Trop. Dis. 5:e1244.
9. Dussart P, et al. 2006. Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum. Clin. Vaccine Immunol. 13:1185-1189.
10. Dussart P, et al. 2008. Evaluation of two new commercial tests for the diagnosis of acute dengue virus infection using NS1 antigen detection in human serum. PLoS Negl. Trop. Dis. 2:e280.
11. Duyen HT, et al. 2011. Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status. J. Infect. Dis. 203:1292-1300.
12. Flamand M, et al. 1999. Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J. Virol. 73:6104-6110.
13. Guzman MG, et al. 2010. Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl. Trop. Dis. 4:e811.
14. Halstead SB. 2007. Dengue. Lancet 370:1644 -1652.
15. Halstead SB. 2003. Neutralization and antibody-dependent enhancement of dengue viruses. Adv. Virus Res. 60:421- 467.
16. Hang VT, et al. 2009. Diagnostic accuracy of NS1 ELISA and lateral flow rapid tests for dengue sensitivity, specificity and relationship to viraemia and antibody responses. PLoS Negl. Trop. Dis. 3:e360.
17. Harlow E, Lane D. 1988. Antibodies: a laboratory manual, p 564-565. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
18. Khromykh AA, Sedlak PL, Guyatt KJ, Hall RA, Westaway EG. 1999. Efficient trans-complementation of the flavivirus kunjin NS5 protein but not of the NS1 protein requires its coexpression with other components of the viral replicase. J. Virol. 73:10272-10280.
19. Kumarasamy V, et al. 2007. Evaluation of a commercial dengue NS1 antigen-capture ELISA for laboratory diagnosis of acute dengue virus infection. J. Virol. Methods 140:75-79.
20. Lapphra K, et al. 2008. Evaluation of an NS1 antigen detection for diagnosis of acute dengue infection in patients with acute febrile illness. Diagn. Microbiol. Infect. Dis. 60:387-391.
21. Libraty DH, et al. 2002. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J. Infect. Dis. 186:1165-1168.
22. Low JG, et al. 2006. Early Dengue infection and outcome study (EDEN)-study design and preliminary findings. Ann. Acad. Med. Singapore 35:783-789.
23. Mackenzie JM, Jones MK, Young PR. 1996. Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220:232-240.
24. McBride WJH, Vasudevan SG. 1995. Relationship of a dengue 2 isolate from Townsville, 1993, to international isolates. Commun. Dis. Intell. 19:522-523.
25. Paradkar PN, Ooi EE, Hanson BJ, Gubler DJ, Vasudevan SG. 2011. Unfolded protein response (UPR) gene expression during antibodydependent enhanced infection of cultured monocytes correlates with dengue disease severity. Biosci. Rep. 31:221-230.
26. Rathore AP, et al. 2011. Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model. Antiviral Res. 92:453- 460.
27. Rozen-Gagnon K, Moreland NJ, Ruedl C, Vasudevan SG. 2012. Expression and immunoaffinity purification of recombinant dengue virus 2 NS1 protein as a cleavable SUMOstar fusion. Protein Expr. Purif. 82:20 -25.
28. Schul W, Liu W, Xu HY, Flamand M, Vasudevan SG. 2007. A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J. Infect. Dis. 195:665- 674.
29. Tan GK, et al. 2010. A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice. PLoS Negl. Trop. Dis. 4:e672.
30. Tricou V, Minh NN, Farrar J, Tran HT, Simmons CP. 2011. Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue. PLoS Negl. Trop. Dis. 5:e1309.
31. Wilson JR, de Sessions PF, Leon MA, Scholle F. 2008. West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J. Virol. 82: 8262-8271.
32. Winkler G, Maxwell SE, Ruemmler C, Stollar V. 1989. Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology 171:302-305.
33. Young PR, Hilditch PA, Bletchly C, Halloran W. 2000. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J. Clin. Microbiol. 38:1053-1057.
34. Zellweger RM, Prestwood TR, Shresta S. 2010. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7:128-139.